Changlin Pang
Biography
Changlin Pang, PhD., Platform Integration Lead of InchFab Inc., received the B.S. and M.S. degrees in Precision instruments from Tsinghua University, China in 2002, and his M.S. and Ph.D. degrees in Electrical Engineering from Caltech with his Ph.D. project of polymer neural electrodes for a neural prosthesis system in 2007. Dr. Pang invented the world’s smallest implantable programmable ocular drug delivery pump for AMD treatment, started Replenish, Inc. which was invested by Alcon in 2008. He later joined Alcon for commercializing this micropump in 2015. Dr. Pang was the Co-founder and CTO of Golden Eye Bionics from 2017 to 2024 to develop and commercialize a new generation of retinal prosthesis products. Dr. Pang has more than 50 approved and pending patent applications.
Company Profile
InchFab
The founders of InchFab developed the core fabrication technology that now drives InchFab – a ultra-low-cost scalable “micro-sized” fab platform. Today InchFab uses this platform to provide highly flexible and cost-effective foundry services to its customers and partners. In 2025 InchFab announced that the complete microfab equipment set and facility is being offered. This turnkey wafer fab is a low capex alternative to anything available. It’s ideal for startups, universities and low to medium volume corporations.